Modular Medical, Inc. (MODD)
| Market Cap | 23.54M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -26.78M |
| Shares Out | 5.41M |
| EPS (ttm) | -14.75 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 28,176 |
| Open | 4.360 |
| Previous Close | 4.350 |
| Day's Range | 4.275 - 4.460 |
| 52-Week Range | 3.552 - 34.500 |
| Beta | -0.00 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Feb 17, 2026 |
About MODD
Modular Medical, Inc. operates as a medical device company. The company focuses on the design, development, and commercialization of insulin pumps. It also offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. Modular Medical, Inc. is headquartered in San Diego, California. [Read more]
Financial Performance
Financial StatementsNews
Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock
SAN DIEGO, CA / ACCESS Newswire / April 19, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery, today announced t...
Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
SAN DIEGO, CA / ACCESS Newswire / April 16, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery, today announced t...
Modular Medical Receives FDA 510(k) Clearance for Pivot Tubeless Insulin Patch Pump
First Removable 2-Part Design Targets $3 Billion "Almost-Pumper" Market with Expected Q2 2026 initial deployment. Key Milestones & Investment Highlights: FDA 510(k) Clearance Achieved: Pivot™ pump now...
Modular Medical Announces 1-for-30 Reverse Stock Split
SAN DIEGO, CA / ACCESS Newswire / March 26, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), an innovative insulin delivery technology company, today announced that it ...
Modular Medical Announces $12.0 Million Public Offering Priced at a Premium to Market
SAN DIEGO, CA / ACCESS Newswire / March 3, 2026 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump...
Modular Medical Achieves Key Manufacturing Milestone for Pivot Tubeless Insulin Patch Pump
Targeting Q1 2026 Launch, Subject to FDA Clearance Key Highlights: Cartridge & Infusion Set Lots in Production: Validation production lots now being produced for launch, derisking commercial-scale pro...
Modular Medical Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Rule
SAN DIEGO, CA / ACCESS Newswire / December 31, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch ...
Modular Medical Announces Pricing of $4.68 Million Public Offering
SAN DIEGO, CA / ACCESS Newswire / December 10, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch ...
Modular Medical Announces Proposed Public Offering
SAN DIEGO, CA / ACCESS Newswire / December 9, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical"), an insulin delivery technology company with the first FDA-cleared patch pump designed spec...
Modular Medical Receives IRB Approval to Deliver Insulin Using Pivot Patch Pump
Study to Deliver Insulin to Internal Testers Wearing Continuous Glucose Monitors SAN DIEGO, CA / ACCESS Newswire / November 17, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Co...
Modular Medical Submits Pivot Tubeless Insulin Patch Pump for FDA 510(k) Clearance
-Targets $3 Billion "Almost-Pumper" Market with First Simplified and Removable/Replaceable Insulin Patch Pump - Aims to Improve Patient and Clinician Experience for the Care of Diabetes SAN DIEGO, CA ...
Modular Medical Announces Successful Validation of Controller Line for Pivot Insulin Delivery System
Key Highlights: Pivot Controller Line Validated: Manufacturing line has now been validated for human-use production in support of expected Q1 2026 market launch. Pivot will be First Two-Part Tubeless ...
Modular Medical Announces Ongoing Progress to Obtain CE Mark
Key Highlights: Pivot continues to progress toward CE Mark certification in 2026 Stage 1 ISO Audit completed with Stage 2 planned for 1H2026 SAN DIEGO, CA / ACCESS Newswire / October 28, 2025 / Modula...
Modular Medical Appoints David Bosshard to Lead its International Expansion for the Pivot Insulin Delivery System
-Seasoned Executive with Proven Track Record in International Pump Launches to Accelerate Global Adoption of User Friendly, Affordable Patch Pumps SAN DIEGO, CA / ACCESS Newswire / October 6, 2025 / M...
Modular Medical Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
SAN DIEGO, CA / ACCESS Newswire / September 29, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery technology targeting the $3 bil...
Modular Medical Receives IRB Approval for Pivot Insulin Delivery System Feasibility Study
-Study to Evaluate Usability and Extended Wear for Next-Generation Tubeless Patch Pump SAN DIEGO, CA / ACCESS Newswire / September 15, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or ...
Modular Medical Announces Completion of Clinical Study of MODD1 Pump
- Use of MODD1 on clinicians with Type 1 diabetes SAN DIEGO, CA / ACCESS Newswire / September 11, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery t...
Modular Medical Announces Completion of MODD1 Cartridge Production and Commencement of Pivot Conversion
-More than 6,000 MODD1 cartridges produced - Conversion to Pivot-ready manufacturing in preparation for product launch in 1Q26 SAN DIEGO, CA / ACCESS Newswire / August 26, 2025 / Modular Medical, Inc....
Modular Medical Announces Next-Generation Pivot Insulin Pump at ADCES and Introduction of Level Ex Gamified Training Collaboration
-Debuting a "coming soon" campaign for tubeless Pivot patch pump - Expects special 510(k) filing for Pivot product in October - Will introduce first level of its gamified training application develope...
Modular Medical Announces First Human Use of MODD1 Pump Delivering Insulin
- Use of MODD1 on clinician with Type 1 diabetes - Modular Medical intends to deploy the MODD1 on a larger number of clinicians in mid August SAN DIEGO, CA / ACCESS Newswire / August 6, 2025 / Modular...
Modular Medical Announces MODD1 Cartridge Line Validated for Human-Use Production
-Line has been in production at risk since early July - Production to continue until late August when conversion to Pivot manufacturing will begin SAN DIEGO, CA / ACCESS Newswire / August 4, 2025 / Mo...
Modular Medical to Present Data from Study Examining Pump Delivery of a GLP-1R Agonist at the ADA 85th Scientific Sessions
SAN DIEGO, CA / ACCESS Newswire / June 16, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump...
Modular Medical Appoints Industry Veteran Jeff Goldberg to Board of Directors
SAN DIEGO, CA / ACCESS Newswire / May 28, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump ...
Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "Making Diabetes Management Simpler: The New Era of Insulin Therapy" Featuring Modular Medical CEO - Wednesday, May 28, 2025
Meet with Modular Medical CEO Jeb Besser There are 1.9 million individuals with Type 1 Diabetes in the US. 100% of patient population require daily insulin injection.
Modular Medical to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
SAN DIEGO, CA / ACCESS Newswire / May 22, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump ...